alendronate has been researched along with Blood Pressure, High in 7 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The arterial hypertension is a disorder characterized by relevant alterations in the bone tissue." | 1.35 | Local action of sodium alendronate in bone repair of spontaneously hypertensive rat (SHR). ( Chin, CM; Faig-Leite, H; Fernandes, RG; Nobre, MD, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Fede, O | 1 |
| Fusco, V | 1 |
| Matranga, D | 1 |
| Solazzo, L | 1 |
| Gabriele, M | 1 |
| Gaeta, GM | 1 |
| Favia, G | 1 |
| Sprini, D | 1 |
| Peluso, F | 1 |
| Colella, G | 1 |
| Vescovi, P | 1 |
| Campisi, G | 1 |
| López-Cedrún, JL | 1 |
| Sanromán, JF | 1 |
| García, A | 1 |
| Peñarrocha, M | 1 |
| Feijoo, JF | 1 |
| Limeres, J | 1 |
| Diz, P | 1 |
| Casiano, V | 1 |
| Kalish, VB | 1 |
| Unwin, B | 1 |
| Nobre, MD | 1 |
| Fernandes, RG | 1 |
| Chin, CM | 1 |
| Faig-Leite, H | 1 |
| Li, L | 2 |
| Chen, GP | 2 |
| Yang, Y | 2 |
| Ye, Y | 1 |
| Yao, L | 2 |
| Hu, SJ | 2 |
| Fu, M | 1 |
| Wu, T | 1 |
| Zhang, XQ | 1 |
| Zethraeus, N | 1 |
| Ström, O | 1 |
| Borgström, F | 1 |
| Kanis, JA | 1 |
| Jönsson, B | 1 |
7 other studies available for alendronate and Blood Pressure, High
| Article | Year |
|---|---|
Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.
Topics: Administration, Oral; Adrenal Cortex Hormones; Age Factors; Aged; Aged, 80 and over; Alendronate; Bi | 2013 |
Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Alendronate; Bisphosphonate-Associated Osteonec | 2013 |
An unusual adverse event from a common medication in an individual with dementia.
Topics: Administration, Oral; Aged, 80 and over; Alendronate; Alzheimer Disease; Deglutition Disorders; Fema | 2014 |
Local action of sodium alendronate in bone repair of spontaneously hypertensive rat (SHR).
Topics: Alendronate; Analysis of Variance; Animals; Bone Density Conservation Agents; Bone Regeneration; Dis | 2008 |
Chronic inhibition of farnesyl pyrophosphate synthase attenuates cardiac hypertrophy and fibrosis in spontaneously hypertensive rats.
Topics: Alendronate; Animals; Cardiomegaly; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrosis; G | 2010 |
Chronic inhibition of farnesyl pyrophosphate synthase improves endothelial function in spontaneously hypertensive rats.
Topics: Alendronate; Animals; Aorta, Thoracic; Dimethylallyltranstransferase; Endothelium, Vascular; Enzyme | 2010 |
The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden.
Topics: Aged; Aged, 80 and over; Alendronate; Antihypertensive Agents; Bone Density Conservation Agents; Cos | 2008 |